Serotonin 1A Receptor Pharmacotherapy and Neuroplasticity in Spinal Cord Injury
Open Access
- 11 April 2022
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (4) , 460
Abstract
Spinal cord injury is associated with damage in descending and ascending pathways between brainstem/cortex and spinal neurons, leading to loss in sensory-motor functions. This leads not only to locomotor reduction but also to important respiratory impairments, both reducing cardiorespiratory engagement, and increasing cardiovascular risk and mortality. Moreover, individuals with high-level injuries suffer from sleep-disordered breathing in a greater proportion than the general population. Although no current treatments exist to restore motor function in spinal cord injury (SCI), serotoninergic (5-HT) 1A receptor agonists appear as pharmacologic neuromodulators that could be important players in inducing functional improvements by increasing the activation of spared motoneurons. Indeed, single therapies of serotoninergic 1A (5-HT1A) agonists allow for acute and temporary recovery of locomotor function. Moreover, the 5-HT1A agonist could be even more promising when combined with other pharmacotherapies, exercise training, and/or spinal stimulation, rather than administered alone. In this review, we discuss previous and emerging evidence showing the value of the 5HT1A receptor agonist therapies for motor and respiratory limitations in SCI. Moreover, we provide mechanistic hypotheses and clinical impact for the potential benefit of 5-HT1A agonist pharmacology in inducing neuroplasticity and improving locomotor and respiratory functions in SCI.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (#HL117037)
- Paralyzed Veterans of America (JA Taylor)
- Fondation du Souffle (Doctoral support (IV))
This publication has 56 references indexed in Scilit:
- Cardiovascular disease and spinal cord injuryNeurology, 2013
- The upright posture improves plantar stepping and alters responses to serotonergic drugs in spinal ratsThe Journal of Physiology, 2012
- Functional and Physiological Effects of Treadmill Training Induced by Buspirone, Carbidopa, and L-DOPA in Clenbuterol-Treated Paraplegic MiceNeurorehabilitation and Neural Repair, 2011
- The time course of serotonin 2A receptor expression after spinal transection of rats: an immunohistochemical studyNeuroscience, 2011
- Oral administration of a tri‐therapy for central pattern generator activation in paraplegic mice: Proof‐of‐concept of efficacyBiotechnology Journal, 2010
- Distribution and Localization of 5-HT 1A Receptors in the Rat Lumbar Spinal Cord after Transection and DeafferentationJournal of Neurotrauma, 2009
- Epidural stimulation: Comparison of the spinal circuits that generate and control locomotion in rats, cats and humansExperimental Neurology, 2008
- Buspirone in Rett syndrome respiratory dysfunctionBrain and Development, 2005
- Spinal cord serotonin: A biochemical and immunohistochemical study following transectionBrain Research, 1984
- Respiratory responses of the anesthetized rabbit to vagotomy and thoracic dorsal rhizotomyRespiration Physiology, 1973